Reclassification of staphylococcus aureus nasal carriage types

Journal of Infectious Diseases

Volumn 199, Issue 12, 2009, Pages 1820-1826

  Van Belkum, Alex ^a   Verkalk, Nelianne J ^a   De Vogel, Corné P ^a   Boelens, Hélène A ^a   Verveer, Jeroen ^a   Nouwen, Jan L ^a   Verbrugh, Henri A ^a   Wertheim, Heiman F L ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PSEUDOMONIC ACID; ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SURVIVAL; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; BLOOD; CLASSIFICATION; HETEROZYGOTE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; NOSE MUCOSA; OINTMENT;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; CARRIER STATE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUPIROCIN; NASAL MUCOSA; OINTMENTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 67650508387     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/599119     Document Type: Article

References (37)

1. Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5:751 62.
2. Weidenmaier C, Kokai-Kun JF, Kristian SA, et al. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med 2004; 10:243-5.
3. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double blind, randomized, placebo controlled study. Clin Infect: Dis 2002; 35:353-8.
4. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002; 346: 1871-7.
5. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001; 344: 11-6.
6. Williams RE. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 1963; 27:56-71.
7. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10:505-20.
8. Wertheim HF, Verveer J, Boelens HA, van Belkum A, Verbrugh HA, Vos MC. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Antimicrob Agents Chemother 2005; 49:1465-7.
9. Leigh DA, Joy G. Treatment of familial staphylococcal infection: comparison of mupirocin nasal ointment and chlorhexidine/neomycin (Naseptin) cream in eradication of nasal carriage. J Antimicrob Chemother 1993;31:909-17.
10. Watanakunakorn C, Axelson C, Bota B, Stahl C. Mupirocin ointment with and without Chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents. Am J Infect. Control 1995; 23:306-9.
11. Eriksen NH, Espersen F, Rosdahl VT, Jensen K. Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect 1995; 115:51-60.
12. Hu L, Umeda A, Kondo S, Amako K. Typing of Staphylococcus aureus colonising human nasal carriers by pulsed-field gel electrophoresis. J Med Microbiol 1995; 42:127-32.
13. Peacock SJ, Justice A, Griffiths D, et al. Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Microbiol 2003; 41: 5718-25.
14. Cole AM, Tahk S, Oren A, et al. Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol 2001; 8:1064-9.
15. Goslings WRO, Buchli K. Nasal carriage rate of antibiotic-resistant: staphylococci. Arch Int Med 1958; 102:691-715.
16. Lipsky BA, Pecoraro RE, Chen MS, Koepsell TD. Factors affecting staphylococcal colonization amongNIDDM outpatients. Diabetes Care 1987; 10:483-6.
17. Yu VL, Goetz A, Wagener M, et al. Staphybcoccus aureus nasal carriage and infection in patients on hemodialysis: efficacy of antibiotic prophylaxis. N Engl J Med. 1986; 315:91-6.
18. Luzar MA, Coles GA, Faller B, et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990; 322:505-9.
19. IIoeger PH, Lenz W, Boutonnier A, Fournier JM. Staphylococcal skin colonization in children with atopic dermatitis: prevalence, persistence, and transmission of toxigenic and nontoxigenic strains. J Infect Dis 1992; 165:1064-8.
20. Ho PL, Wang TK, Ching P, et al. Epidemiology and genetic diversity of methicillin-resistant Staphylococcus aureus strains in residential care homes for elderly persons in Hong Kong. Infect Control Hosp Epidemiol 2007; 28:6718.
21. VandenBergh MF, Yzerman EP, van Belkum A, Boelens HA, Sijmons M, Verbrugh HA. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Microbiol 1999; 37: 3133-40.
22. Corrigan RM, Rigby D, Handley P, Foster TJ. The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology 2007; 153:2435-46.
23. Schaffer AC, Solinga RM, Cocchiaro J, et al. Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model. Infect Immun 2006; 74:2145-53.
24. Wertheim HF, Walsh E, Choudhurry R, et al. Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans. PLoS Med 2008; 5:el7.
25. Nouwen JL, Ott A, Kluytmans-Vandenbergh MF, et al. Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a "culture rule." Clin Infect Dis 2004; 39:806-11.
26. Nouwen J, Boelens H, van Belkum A, Verbrugh H. Human factor in Staphylococcus aureus nasal carriage. Infect Immun 2004; 72:6685 8.
27. Wertheim H, Verbrugh HA, van Pelt C, de Man P, van Belkum A, Vos MC. Improved detection of methicillin-resistant Staphylococcus aureus using phenyl mannitol broth containing aztreonam and ceftizoxime. J Clin Microbiol 2001; 39:2660-2.
28. Feny T, Thomas D, Genestier AL, et al. Comparative prevalence of su perantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock. Clin Infect Dis 2005; 41:771-7.
29. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28:495 503.
30. Verkaik NJ, de Vogel CP, Boelens HA, et al. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers ofStaphylococcus aureus. J Infect: Dis 2009; 199:625-32.
31. Martins TB, Augustine NH, Hill HR. Development of a multiplexed fluorescent immunoassay for the quantitation of antibody responses to group A streptococci. J Immunol Methods 2006; 316:97-106.
32. Verkaik N, Brouwer E, Hooijkaas H, van Belkum A, van Wamel W. Comparison of carboxylated and Penta-His microspheres for semiquantitative measurement of antibody responses to His-tagged proteins. J Immunol Methods 2008; 335:121-5.
33. Wertheim HF, Vos MC, Ott. A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004; 364:703-5.
34. Nouwen JL, Fieren MW, Snijders S, Verbrugh HA, van Belkum A. Per sistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections. Kidney Int 2005; 67:1084-92.
35. Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D, de Baere GA. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical site infections in orthopedic surgery. Infect Control Hosp Epi demiol 2000; 21:319-23.
36. van den Akker EL, Nouwen JL, Melles DC, et al. Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J Infect Dis 2006; 194:814-8.
37. Emonts M, Uitterlinden AG, Nouwen JL, et al. Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J Infect Dis 2008; 197:1244-53.